{"raw_response": "{\"target_date\": \"2023-07-13\", \"instructions\": [{\"symbol\": \"NVDA\", \"action\": \"buy\", \"quantity\": 543, \"execution_session\": \"market_open\", \"entry_price\": 45.98, \"exit_price\": 46.44, \"exit_reason\": \"1% mean reversion target\", \"notes\": \"CONTRARIAN BUY: -2.41% expected return signals oversold condition. Model predicts down but expecting bounce on mean reversion. Entry at last close, exit at +1%.\"}, {\"symbol\": \"MSFT\", \"action\": \"buy\", \"quantity\": 247, \"execution_session\": \"market_open\", \"entry_price\": 101.24, \"exit_price\": 102.25, \"exit_reason\": \"1% mean reversion target\", \"notes\": \"CONTRARIAN BUY: -1.00% expected return indicates oversold. Fading neural forecast for mean reversion bounce. Conservative 1% profit target.\"}], \"risk_notes\": \"Contrarian strategy assumes neural forecasts reflect recent momentum that will mean-revert. Risk if markets continue trending down beyond model predictions.\", \"metadata\": {\"total_capital_deployed\": 50007.36, \"capital_allocation_plan\": \"Deployed 50% of available capital ($79,880) on two contrarian plays. NVDA gets larger allocation ($24,967) due to stronger oversold signal (-2.41% vs -1.00%). AAPL skipped due to minimal negative expected return (-0.21%) indicating insufficient oversold condition. Remaining 50% cash preserved for risk management.\", \"contrarian_logic\": \"Fading Chronos2 negative forecasts as buy signals. Model expects down moves but contrarian thesis is that negative sentiment already priced in, creating bounce opportunity.\", \"exit_strategy\": \"Conservative 1% profit targets to capture mean reversion bounce while minimizing exposure to continued downtrend risk.\"}}", "model": "claude-sonnet-4-20250514", "input_tokens": 10918, "output_tokens": 519}